183 related articles for article (PubMed ID: 10649622)
1. The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.
Gregorek H; Madaliński K; Woynarowski M; Mikołajewicz J; Syczewska M; Socha J
Vaccine; 2000 Jan; 18(13):1210-7. PubMed ID: 10649622
[TBL] [Abstract][Full Text] [Related]
2. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status.
Tsai TH; Huang CF; Wei JC; Ho MS; Wang L; Tsai WY; Lin CC; Xu FL; Yang CC
Viral Immunol; 2006; 19(2):277-84. PubMed ID: 16817770
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapy.
Gregorek H; Madaliński K; Woynarowski M; Mikolajewicz J; Syczewska M; Socha J
J Infect Dis; 2000 Jun; 181(6):2059-62. PubMed ID: 10837193
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections.
Rath S; Devey ME
Clin Exp Immunol; 1988 Apr; 72(1):164-7. PubMed ID: 3396217
[TBL] [Abstract][Full Text] [Related]
5. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
[TBL] [Abstract][Full Text] [Related]
6. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
7. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccinees.
Wang L; Lin SJ; Tsai JH; Tsai CH; Tsai CC; Yang CC
Med Microbiol Immunol; 2005 Jan; 194(1-2):33-8. PubMed ID: 15278448
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of serum IgG subclass distributions and anti-HBs response in healthy adults after hepatitis B vaccination].
Dinç But A; Ersoy Y; Ozerol IH; Firat M
Mikrobiyol Bul; 2005 Oct; 39(4):483-90. PubMed ID: 16544550
[TBL] [Abstract][Full Text] [Related]
10. [Immune response for phase I clinical trial of a hepatitis B immunogenic complex therapeutic vaccine, YIC].
Liu SA; Xu DZ; Zhang JP; Huang KL; Yao J; Xu LF; Yuan ZH; Wen YM
Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):89-92. PubMed ID: 16494774
[TBL] [Abstract][Full Text] [Related]
11. Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.
Da Villa G; Pelliccia MG; Peluso F; Ricciardi E; Sepe A
Res Virol; 1997; 148(2):109-14. PubMed ID: 9108609
[TBL] [Abstract][Full Text] [Related]
12. Selectivity in IgG subclass response to hepatitis B vaccine in infants born to HBsAg-positive mothers.
Rossi ME; Azzari C; Resti M; Appendino C; Pezzati P; Vierucci A
Clin Exp Immunol; 1988 May; 72(2):196-200. PubMed ID: 3409544
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
14. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
16. Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine.
Honorati MC; Borzì RM; Dolzani P; Toneguzzi S; Facchini A
Int J Clin Lab Res; 1997; 27(3):202-6. PubMed ID: 9352385
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
18. Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.
Da Villa G; Peluso F; Picciotto L; Bencivenga M; Elia S; Pelliccia MG
Vaccine; 1996 Nov; 14(16):1503-5. PubMed ID: 9014290
[TBL] [Abstract][Full Text] [Related]
19. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
20. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
